# Drug Effectiveness Analysis

## Objective
To analyze the performance of Capomulin, a drug developed by Pymaceuticals Inc., in treating squamous cell carcinoma (SCC) in mice, and to compare its efficacy with other treatment regimens. This analysis involves generating comprehensive tables and figures that summarize the results of a 45-day study involving 250 mice, to support the technical report and provide a top-level summary for the executive team.
